Medical Information Technology, Inc.
Technology · Services-Prepackaged Software · MA · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | |
|---|---|---|---|---|---|---|
| Revenue | $493.8M | $488.2M | $480.9M | $462.3M | $475.5M | $517.0M |
| Operating income | $64.5M | $64.8M | $64.0M | $69.9M | $67.1M | $108.9M |
| Net income | $180.2M | $56.2M | $77.4M | $72.9M | $70.1M | $123.5M |
| Total assets | $669.5M | $569.5M | $619.2M | $634.3M | $652.5M | $704.6M |
| Total liabilities | $111.7M | $108.6M | $122.3M | $110.8M | $114.1M | $128.3M |
| Equity | $557.8M | $460.9M | $496.9M | $523.5M | $538.4M | $576.3M |
| EPS (diluted) | — | — | — | $1.96 | $1.88 | $3.33 |
| Shares out. | 37.2M | 37.2M | 37.2M | 37.2M | 37.2M | 37.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2019- Operating margin
- 13.1%
- Net margin
- 36.5%
- Return on equity
- 32.3%
- Return on assets
- 26.9%
- Return on capital (ROCE)
- 10.7%
- Liabilities / assets
- 16.7%
- Debt / equity
- 0.20×
- Book value / share
- $15.00
- Revenue growth (YoY)
- 1.2%
- Net income growth (YoY)
- 220.5%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2019- Accruals / assets
- 19.9%high accruals
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 5 good- High accruals — earnings-quality risk
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Modified shareholder rights · Amended charter or bylaws · Shareholder voteNov 30, 2020
- Other material eventDec 15, 2014
- Changed auditorOct 9, 2014
- Shareholder voteJul 2, 2010
- Prior financials not reliable (restatement)Feb 6, 2009
- Item 4Oct 28, 2002
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GNOTICE OF TERMINATION UNDER SECTION 12(G)Dec 1, 2020
- SC 13E3/ARULE 13E-3 TRANSACTION STATEMENTDec 1, 2020
- 8-KCUURRENT REPORTNov 30, 2020
- S-8 POSPOST-EFFECTIVE AMENDMENTSNov 30, 2020
- 4PRIMARY DOCUMENTNov 24, 2020
- 4PRIMARY DOCUMENTNov 24, 2020
- 4PRIMARY DOCUMENTNov 24, 2020
- 4PRIMARY DOCUMENTNov 10, 2020
- CORRESPNov 5, 2020
- SC 13E3/ASCHEDULE 13E-3 AMENDMENT 2Nov 5, 2020
- DEF 14AREVERSE STOCK SPLIT DEFINITIVE PROXY STATEMENTNov 5, 2020
- UPLOADOct 28, 2020
- CORRESPOct 26, 2020
- SC 13E3/A2ND SCHEDULE 13E-3Oct 26, 2020
- PRER14APRELIMINARY PROXY STATEMENT 1ST AMENDMENTOct 26, 2020
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.